Amylin Pharmaceuticals Inc.

Company Website

9360 Towne Centre Dr., Suite 110
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Amylin Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

Market Cap as of 06/26/2012

$4,582,660,156

Market Cap as of 01/04/2012

$1,633,981,000

Market Cap as of 06/20/2011

$1,662,606,000

Market Cap as of 01/06/2011

$2,113,855,000

Exchange and Ticker Symbol

Nasdaq: AMLN

Fields of Research

Discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases

Major Products

Bydureon

View all the companies in San Diego Publicly Traded Companies

Amylin Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Exchange

NASDAQ GS

Ticker

AMLN

Executives

Ginger Graham (profile)

  • Chief Executive Officer

Daniel Bradbury (profile)

  • Chief Executive Officer
  • President

Howard Greene (profile)